ClinicalTrials.gg
CompletedNCT05014269Updated Aug 20, 2021

Phacoemulsification in Patients With Corneal Opacities

An observational study in Senile Cataract, sponsored by Assiut University. Completed. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-08-20.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
10
Ages
50 Years and older
Sex
All
01

Study summary

In this retrospective case series, the feasibility of performing phacoemulsification using slit illumination in eyes with corneal opacity was assessed.

Read the detailed description

Corneal opacity is often encountered in patients seeking senile cataract surgery in developing countries. Corneal opacity impairs the intraoperative visualization during cataract surgery which increases the risk of copmlications.

Several techniques were described to enhance the intraoperative visualization such as the use of anterior endoscopy, chandeiler retroillumination, and anterior chamber endoillumination. All these techniques require costly instrumentation.

the aim of this study was to assess the feasibility of performing phacoemulsification using slit illumination of the surgical microscope without the need of additional instruments, and report the visual outcome.

02

Conditions studied

  • Senile Cataract

Browse trials for

Keywords

  • Senile Cataract
  • Corneal opacity
  • Phacoemulsification
03

In context

Corneal Opacity

37 studies on the registry are indexed under Corneal Opacity; 5 are open to participants now.

This study's enrollment of 10 is below the median of 45 across 14 observational studies indexed under Corneal Opacity.

Browse Corneal Opacity studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with visually significant senile cataract and corneal opacities

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The presence of visually significant senile cataract.
  • A recent history of progressive diminution of vision within few months.
  • Stable density and size of a preexisting trachomatous corneal opacity that does not impair the pupil or lens visualization after pupillary dilatation.

Exclusion criteria

Exclusion Criteria:

  • History of trauma, infectious corneal ulcers, or intraocular surgery.
  • Coexisting ocular diseases e.g. glaucoma, retinal detachment, and vitreous hemorrhage.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
10 participants (actual)
Patient registry
No

Interventions

  • ProcedurePhacoemulsification in eyes with corneal opacities

    senile cataract extraction using lens emulsification under the slit illuimnation of the surgical microscope

06

What researchers measure

Primary outcomes

  1. The rate of intra-operative complications of phacoemulsification in eyes with corneal opacities using the slit ilumination of the surgical microscope.

    the frequency of the intraoperative complications of phacoemulsification in eyes with corneal opacities

    Time frame: 3 months

Secondary outcomes

  1. Visual outcome of phacoemulsification in eyes with corneal opacities

    meaurement of the change of the distance corrected visual acuity bafoer after phacoemulsification using Snellen chart

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05014269
Lead sponsor
Assiut University
Responsible party
Mahmoud F. Rateb (Assistant professor of Ophthalmology, Assiut University) — Principal investigator
First posted
Aug 20, 2021
Start date
Jan 1, 2015
Primary completion
Dec 30, 2017
Completion
Jul 31, 2018
Last update
Aug 20, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion